"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes

Advanced Drug Delivery Reviews

Volumn 56, Issue 7, 2004, Pages 931-946

  Fattal, Elias ^a   Couvreur, Patrick ^a   Dubernet, Catherine ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Oligonucleotides; pH sensitive liposomes; Phosphatidylethanolamine

Indexed keywords

BIOLOGICAL MEMBRANES; DISEASES; GENES; LIPIDS; MICELLES; NEGATIVE IONS; OLIGOMERS; TUMORS;

ENDOSOMAL MEMBRANES; GENE EXPRESSION; INFLAMMATORY DISEASES; OLIGONUCLEOTIDES;

CONTROLLED DRUG DELIVERY;

1,2 DIOLEOYL 3 SUCCINYLGLYCEROL; 1,2 DIPALMITOYL 3 SUCCINYLGLYCEROL; ADEFOVIR; ANION; ANTISENSE OLIGONUCLEOTIDE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; IMMUNOLIPOSOME; LIPOSOME; MACROGOL; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; POLYMER; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; UNCLASSIFIED DRUG;

ACIDITY; CELL TRANSPORT; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG STABILITY; DRUG STRUCTURE; DRUG TARGETING; DRUG TRANSPORT; ENCAPSULATION; ENDOCYTOSIS; ENDOSOME; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MICELLE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

EID: 1942534976     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.037     Document Type: Article

References (79)

1. Stein C.A., Cheng Y.C. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science. 261:1993;1004-1012.
2. Crooke S.T. Progress toward oligonucleotide therapeutics: pharmacodynamic properties. FASEB J. 7:1993;533-539.
3. Mergny J.L., Duval-Valentin G., Nguyen C.H., Perrouault L., Faucon B., Rougee M., Montenay-Garestier T., Bisagni E., Helene C. Triple helix-specific ligands. Science. 256:1992;1681-1684.
4. Beal P.A., Dervan P.B. Second structural motif for recognition of DNA by oligonucleotide-directed triple-helix formation. Science. 251:1991;1360-1363.
5. Helene C. The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anti-Cancer Drug Des. 6:1991;569-584.
6. Roberts R.W., Crothers D.M. Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition. Science. 258:1992;1463-1466.
7. Been M.D. Nucleases that are RNA. Linn S.M., Lloyd R.S., Roberts R.S. Nucleases. 1993;407-437 Cold Spring Laboratory, Cold Spring Harbor, NY.
8. Francois J.C., Thuong N.T., Helene C. Recognition and cleavage of hairpin structures in nucleic acids by oligodeoxynucleotides. Nucleic Acids Res. 22:1994;3943-3950.
9. Hanvey J.C., Peffer N.J., Bisi J.E., Thomson S.A., Cadilla R., Josey J.A., Ricca D.J., Hassman C.F., Bonham M.A., Au K.G., et al. Antisense and antigene properties of peptide nucleic acids. Science. 258:1992;1481-1485.
10. Ellington A.D., Szostak J.W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature. 355:1992;850-852.
11. Burgess T.L., Fisher E.F., Ross S.L., Bready J.V., Qian Y.X., Bayewitch L.A., Cohen A.M., Herrera C.J., Hu S.S., Kramer T.B., et al. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;4051-4055.
12. Castier Y., Chemla E., Nierat J., Heudes D., Vasseur M.A., Rajnoch C., Bruneval P., Carpentier A., Fabiani J.N. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is non-specific. J. Cardiovasc. Surg. (Torino). 39:1998;1-7.
13. Bennett C.F. Antisense oligonucleotides: is the glass half full or half empty? Biochem. Pharmacol. 55:1998;9-19.
14. Galbraith W.M., Hobson W.C., Giclas P.C., Schechter P.J., Agrawal S. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey. Antisense Res. Dev. 4:1994;201-206.
15. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
16. Le Doan T. Cell binding and internalisation of oligonucleotides. Stp Pharma Sci. 11:2002;75-82.
17. Stein C.A., Mori K., Loke S.L., Subasinghe C., Shinozuka K., Cohen J.S., Neckers L.M. Phosphorothioate and normal oligodeoxyribonucleotides with 5′-linked acridine: characterization and preliminary kinetics of cellular uptake. Gene. 72:1988;333-341.
18. Loke S.L., Stein C.A., Zhang X.H., Mori K., Nakanishi M., Subasinghe C., Cohen J.S., Neckers L.M. Characterization of oligonucleotide transport into living cells. Proc. Natl. Acad. Sci. USA. 86:1989;3474-3478.
19. Zhao Q., Matson S., Herrera C.J., Fisher E., Yu H., Krieg A.M. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3:1993;53-66.
20. Nakai D., Seita T., Terasaki T., Iwasa S., Shoji Y., Mizushima Y., Sugiyama Y. Cellular uptake mechanism for oligonucleotides: involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15. J. Pharmacol. Exp. Ther. 278:1996;1362-1372.
21. Gao W.Y., Storm C., Egan W., Cheng Y.C. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol. Pharmacol. 43:1993;45-50.
22. Temsamani J., Kubert M., Tang J., Padmapriya A., Agrawal S. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense Res. Dev. 4:1994;35-42.
23. Krieg A.M., Gmelig-Meyling F., Gourley M.F., Kisch W.J., Chrisey L.A., Steinberg A.D. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Res. Dev. 1:1991;161-171.
24. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors. Proc. Natl. Acad. Sci. USA. 86:1989;6454-6458.
25. Wu-Pong S., Weiss T.L., Hunt C.A. Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharm. Res. 9:1992;1010-1017.
26. Chin D.J., Green G.A., Zon G., Szoka F.C. Jr., Straubinger R.M. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol. 2:1990;1091-1100.
27. Ketting R.F., Fischer S.E., Bernstein E., Sijen T., Hannon G.J., Plasterk R.H. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15:2001;2654-2659.
28. Vaucheret H., Beclin C., Fagard M. Post-transcriptional gene silencing in plants. J. Cell Sci. 114:2001;3083-3091.
29. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
30. Caplen N.J., Parrish S., Imani F., Fire A., Morgan R.A. Specific inhibition of gene expression by small double stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA. 98:2001;9742-9747.
31. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296:2002;1000-1004.
32. Scherr M., Battmer K., Winkler T., Heidenreich O., Ganser A., Eder M. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood. 101:2003;1566-1569.
33. Vickers T.A., Koo S., Bennett C.F., Crooke S.T., Dean N.M., Baker B.F. Efficient reduction of target RNA's by siRNA and RNase H dependent antisense agents: a comparative analysis. J. Biol. Chem. 278:2002;7108-7118.
34. Couvreur P., Fattal E., Malvy C., Dubernet C. pH-sensitive liposomes: an intelligent system for the delivery of antisens oligonucleotides. J. Liposome Res. 7:1997;1-18.
35. Gerasimov O.V., Boomer J.A., Qualls M.M., Thompson D.H. Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv. Drug Deliv. Rev. 38:1999;317-338.
36. Cevc G., Richardsen H. Lipid vesicles and membrane fusion. Adv. Drug Deliv. Rev. 38:1999;207-232.
37. Hafez I.M., Cullis P.R. Roles of lipid polymorphism in intracellular delivery. Adv. Drug Deliv. Rev. 47:2001;139-148.
38. Shalaev E.Y., Steponkus P.L. Phase diagram of 1,2- dioleoylphosphatidylethanolamine (DOPE):water system at subzero temperatures and at low water contents. Biochim. Biophys. Acta. 1419:1999;229-247.
39. Drummond D.C., Zignani M., Leroux J.C. Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 39:2000;409-460.
40. Venugopalan P., Jain S., Sankar S., Singh P., Rawat A., Vyas S.P. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie. 57:2002;659-671.
41. Bergstrand N., Arfvidsson M.C., Kim J.M., Thompson D.H., Edwards K. Interactions between pH-sensitive liposomes and model membranes. Biophys. Chem. 104:2003;361-379.
42. Simoes S., Slepushkin V., Duzgunes N., Pedroso de Lima M.C. On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes. Biochim. Biophys. Acta. 1515:2001;23-37.
43. Meyer O., Papahadjopoulos D., Leroux J.C. Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes. FEBS Lett. 421:1998;61-64.
44. Roux E., Stomp R., Giasson S., Pezolet M., Moreau P., Leroux J.C. Steric stabilization of liposomes by pH-responsive N-isopropylacrylamide copolymer. J. Pharm. Sci. 91:2002;1795-1802.
45. de Oliveira M.C., Fattal E., Couvreur P., Lesieur P., Bourgaux C., Ollivon M., Dubernet C. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in quasi-anhydrous samples. Biochim. Biophys. Acta. 1372:1998;301-310.
46. de Oliveira M.C., Rosilio V., Lesieur P., Bourgaux C., Couvreur P., Ollivon M., Dubernet C. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophys. Chem. 87:2000;127-137.
47. De Oliveira M.C., Dubernet C., Paternostre M., Fattal E., Couvreur P., Ollivon M. pH-sensitive liposomes as a carrier for oligonucleotides (ODN): development of a new methodology to follow physico-chemical changes along with pH of native and ODN loaded liposomes. Stp Pharma Sci. 11:2001;31-44.
48. Straubinger R.M., Duzgunes N., Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett. 179:1985;148-154.
49. Collins D., Huang L. Cytotoxicity of diphtheria toxin A fragment to toxin-resistant murine cells delivered by pH-sensitive immunoliposomes. Cancer Res. 47:1987;735-739.
50. Chu C.J., Dijkstra J., Lai M.Z., Hong K., Szoka F.C. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm. Res. 7:1990;824-834.
51. Skalko-Basnet N., Tohda M., Watanabe H. Delivery of antisense oligonucleotides to neuroblastoma cells. Neuroreport. 11:2000;3117-3121.
52. Skalko-Basnet N., Tohda M., Watanabe H. Uptake of liposomally entrapped fluorescent antisense oligonucleotides in NG108-15 cells: conventional versus pH-sensitive. Biol. Pharm. Bull. 25:2002;1583-1587.
53. Connor J., Huang L. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J. Cell Biol. 101:1985;582-589.
54. Connor J., Huang L. pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugs. Cancer Res. 46:1986;3431-3435.
55. Collins D., Maxfield F., Huang L. Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway. Biochim. Biophys. Acta. 987:1989;47-55.
56. Kono K., Zenitani K., Takagishi T. Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim. Biophys. Acta. 1193:1994;1-9.
57. Mizoue T., Horibe T., Maruyama K., Takizawa T., Iwatsuru M., Kono K., Yanagie H., Moriyasu F. Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. Int. J. Pharm. 237:2002;129-137.
58. Legendre J.Y., Szoka F.C. Jr. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. 9:1992;1235-1242.
59. Milhaud P.G., Compagnon B., Bienvenue A., Philippot J.R. Interferon production of L929 and HeLa cells enhanced by polyriboinosinic acid-polyribocytidylic acid pH-sensitive liposomes. Bioconjug. Chem. 3:1992;402-407.
60. Ropert C., Lavignon M., Dubernet C., Couvreur P., Malvy C. Oligonucleotides encapsulated in pH-sensitive liposomes are efficient toward Friend retrovirus (Vol 183, Pg 879, 1992). Biochem. Biophys. Res. Commun. 192:1993;982.
61. Ropert C., Malvy C., Couvreur P. Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action. Pharm. Res. 10:1993;1427-1433.
62. Ropert C., Mishal Z. Jr., Rodrigues J.M., Malvy C., Couvreur P. Retrovirus budding may constitute a port of entry for drug carriers. Biochim. Biophys. Acta. 1310:1996;53-59.
63. Ropert C., Lavignon M., Imbach J.L., Couvreur P., Malvy C. Inhibition of the Friend retrovirus by antisense oligonucleotides. Indirect evidence for the necessity of forced cellular uptake. Ann. New York Acad. Sci. 660:(334-5):1992;334-335.
64. Duzgunes N., Simoes S., Slepushkin V., Pretzer E., Rossi J.J., De Clercq E., Antao V.P., Collins M.L., de Lima M.C. Enhanced inhibition of HIV-1 replication in macrophages by antisense oligonucleotides, ribozymes and acyclic nucleoside phosphonate analogs delivered in pH-sensitive liposomes. Nucleosides Nucleotides Nucleic Acids. 20:2001;515-523.
65. Lubrich B., van Calker D., Peschka-Suss R. Inhibition of inositol uptake in astrocytes by antisense oligonucleotides delivered by pH-sensitive liposomes. Eur. J. Biochem. 267:2000;2432-2438.
66. Smit M.J., Anderson R. Biochemical mechanisms of hydrogen peroxide- and hypochlorous acid-mediated inhibition of human mononuclear leukocyte functions in vitro: protection and reversal by anti-oxidants. Agents Actions. 36:1992;58-65.
67. Selvam M.P., Buck S.M., Blay R.A., Mayner R.E., Mied P.A., Epstein J.S. Inhibition of HIV replication by immunoliposomal antisense oligonucleotide. Antiviral Res. 33:1996;11-20.
68. Ma D.D., Wei A.Q. Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes. Leuk. Res. 20:1996;925-930.
69. Connor J., Norley N., Huang L. Biodistribution of pH-sensitive immunoliposomes. Biochim. Biophys. Acta. 884:1986;474-481.
70. Liu D., Huang L. Role of cholesterol in the stability of pH-sensitive large unilalellar liposomes prepared by the detergent dialysis method. Biochim. Biophys. Acta. 981:1989;254-260.
71. Collins D., Litzinger D.C., Huang L. Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols. Biochim. Biophys. Acta. 1025:1990;234-242.
72. Liu D., Huang L. Small, but not large unilamellar liposomes composed of dioleylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Biochemistry. 28:1989;7700-7707.
73. De Oliveira M.C., Boutet V., Fattal E., Boquet D., Grognet J.M., Couvreur P., Deverre J.R. Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice. Life Sci. 67:2000;1625-1637.
74. Ponnappa B.C., Dey I., Tu G.C., Zhou F., Aini M., Cao Q.N., Israel Y. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats. J. Pharmacol. Exp. Ther. 297:2001;1129-1136.
75. Kono K., Igawa T., Takagishi T. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim. Biophys. Acta. 1325:1997;143-154.
76. Liu D., Huang L. pH-sensitive, plasma stable liposomes with relatively prolonged residence in circulation. Biochim. Biophys. Acta. 1022:1990;348-354.
77. Mori A., Klibanov A.L., Torchilin V.P., Huang L. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284:1991;263-266.
78. Basanez G., Fidelio G.D., Goni F.M., Maggio B., Alonso A. Dual inhibitory effect of gangliosides on phospholipase C-promoted fusion of lipidic vesicles. Biochemistry. 35:1996;7506-7513.
79. Slepushkin V.A., Simoens S., Dazin P., Newman M.S., Guo L.S., Pedroso de Lima M.C., Duzgunes N. Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J. Biol. Chem. 272:1997;2382-2388.